Ruijun Shen

805 total citations
15 papers, 559 citations indexed

About

Ruijun Shen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ruijun Shen has authored 15 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Ruijun Shen's work include PI3K/AKT/mTOR signaling in cancer (9 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Protein Tyrosine Phosphatases (2 papers). Ruijun Shen is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (9 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Protein Tyrosine Phosphatases (2 papers). Ruijun Shen collaborates with scholars based in United States, Switzerland and China. Ruijun Shen's co-authors include Dimpy Koul, W.K. Alfred Yung, Gordon B. Mills, Yiling Lu, Tiffany A. LaFortune, John F. de Groot, WK Alfred Yung, Samar A. Jasser, Yuexi Shi and Michael A. Davies and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

Ruijun Shen

15 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruijun Shen United States	10	386	124	119	93	77	15	559
Anders Kallin Sweden	12	490 1.3×	140 1.1×	182 1.5×	112 1.2×	41 0.5×	16	740
Donald P. Lesslie United States	8	397 1.0×	58 0.5×	353 3.0×	125 1.3×	71 0.9×	11	687
L. Adam United States	9	279 0.7×	153 1.2×	213 1.8×	106 1.1×	41 0.5×	10	544
Rebecca L. Lynch United States	4	452 1.2×	108 0.9×	143 1.2×	88 0.9×	89 1.2×	4	615
Xiaochong Wu United States	16	665 1.7×	102 0.8×	130 1.1×	118 1.3×	45 0.6×	22	817
Yasemin D. Yazici United States	12	339 0.9×	38 0.3×	269 2.3×	122 1.3×	43 0.6×	14	671
Peihong Ma United States	7	240 0.6×	94 0.8×	128 1.1×	130 1.4×	34 0.4×	8	487
Rachelle L. Dillon Canada	11	539 1.4×	40 0.3×	256 2.2×	158 1.7×	89 1.2×	18	821
Susan Jones‐Bolin United States	9	424 1.1×	185 1.5×	184 1.5×	66 0.7×	52 0.7×	14	769
Liansheng Ning China	8	353 0.9×	39 0.3×	184 1.5×	247 2.7×	44 0.6×	14	557

Countries citing papers authored by Ruijun Shen

Since Specialization

Citations

This map shows the geographic impact of Ruijun Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruijun Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruijun Shen more than expected).

Fields of papers citing papers by Ruijun Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruijun Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruijun Shen. The network helps show where Ruijun Shen may publish in the future.

Co-authorship network of co-authors of Ruijun Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Ruijun Shen. A scholar is included among the top collaborators of Ruijun Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruijun Shen. Ruijun Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Su, Tian, et al.. (2025). A β‐galactosidase activated near‐infrared fluorescent probe for tracking cellular senescence in vitro and in vivo. PubMed. 3(1). e20240062–e20240062. 4 indexed citations

2.

Shen, Ruijun, et al.. (2012). Safety Evaluation Model of Highway Construction based on Fuzzy Grey Theory. Procedia Engineering. 45. 64–69. 6 indexed citations

3.

Koul, Dimpy, Jun Fu, Ruijun Shen, et al.. (2011). Antitumor Activity of NVP-BKM120—A Selective Pan Class I PI3 Kinase Inhibitor Showed Differential Forms of Cell Death Based on p53 Status of Glioma Cells. Clinical Cancer Research. 18(1). 184–195. 132 indexed citations

4.

Markert, Michael, Ruijun Shen, Thomas Trautmann, & Brian D. Guth. (2011). Heart rate correction models to detect QT interval prolongation in novel pharmaceutical development. Journal of Pharmacological and Toxicological Methods. 64(1). 25–41. 10 indexed citations

5.

Koul, Dimpy, Ruijun Shen, Tiffany A. LaFortune, et al.. (2010). Abstract 350: NVP-BKM120: A selective pan-PI3 kinase inhibitor induces G2/M arrest in glioma cell lines via FOXO3a and GADD45a loop. Cancer Research. 70(8_Supplement). 350–350. 5 indexed citations

6.

Koul, Dimpy, et al.. (2007). Targeting PI3K in Human Glioblastoma with PX-866, a small molecule PI3K inhibitor.. Cancer Research. 67. 278–278. 1 indexed citations

7.

Shen, Ruijun & Shuzhong Zhang. (2007). Robust portfolio selection based on a multi-stage scenario tree. European Journal of Operational Research. 191(3). 864–887. 22 indexed citations

8.

Koul, Dimpy, Ruijun Shen, Shishir Shishodia, et al.. (2007). PTEN down regulates AP-1 and targets c-fos in human glioma cells Via PI3-kinase/Akt pathway. Molecular and Cellular Biochemistry. 300(1-2). 77–87. 29 indexed citations

9.

Koul, Dimpy, Ruijun Shen, Shishir Shishodia, et al.. (2006). Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma. Molecular Cancer Therapeutics. 5(3). 637–644. 75 indexed citations

10.

Koul, Dimpy, Yasunari Takada, Ruijun Shen, Bharat B. Aggarwal, & W.K. Alfred Yung. (2006). PTEN enhances TNF-induced apoptosis through modulation of nuclear factor-κB signaling pathway in human glioma cells. Biochemical and Biophysical Research Communications. 350(2). 463–471. 38 indexed citations

11.

Koul, Dimpy, Ruijun Shen, Yiling Lu, et al.. (2005). Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma. Molecular Cancer Therapeutics. 4(11). 1681–1688. 86 indexed citations

12.

Koul, Dimpy, Samar A. Jasser, Yiling Lu, et al.. (2002). Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity. Oncogene. 21(15). 2357–2364. 51 indexed citations

13.

Koul, Dimpy, Samar A. Jasser, Yiling Lu, et al.. (2002). Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity. Oncogene. 21(15). 2357–2364. 51 indexed citations

14.

Koul, Dimpy, et al.. (2002). MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. International Journal of Oncology. 21(3). 469–75. 45 indexed citations

15.

Yeh, Michael W., et al.. (1986). [The study of in vivo and in vitro responses to trichosanthin in the mouse].. PubMed. 19(1). 81–90. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact